Pfizer agrees to allow generic versions of its COVID pill
3 years, 1 month ago

Pfizer agrees to allow generic versions of its COVID pill

Al Jazeera  

Deal with international public health group will allow generic versions of the drug to be made and sold in 95 countries. The agreement between the US company and the UN-backed international public health group Medical Patent Pool would allow producers to manufacture and supply generic versions of the drug in 95 countries without the threat of patent infringement. Still, medical charity Doctors Without Borders said it was “disheartened” by Pfizer’s announcement, noting that a number of countries including Argentina, Brazil, China, and Thailand were excluded from the agreement. “We are disheartened to see yet another restrictive voluntary licence during this pandemic while cases continue to rise in many countries around the world,” said Yuanqiong Hu, a senior legal policy adviser with MSF Access Campaign. “If Pfizer really wants to live up to its promise to contribute to equitable access to this new treatment, it should clearly state that they will not stand in the way of open generic production and competition, instead of signing restrictive voluntary licences, and lift any kind of intellectual property monopoly during this pandemic,” she said.

Production Countries Covid Licence Drug Allow Deal Merck Generic Pfizer Mpp Generic Versions This Pandemic  deal  pfizer  drug  production  countries  covid  allow  companies  technology  versions  pill  generic  agrees  licence

History of this topic

Pfizer to offer low-cost drugs to 45 lower-income nations
2 years, 7 months ago

Pfizer to offer low-cost drugs to 45 lower-income nations

Al Jazeera  

US pharmaceutical giant says it will sell patented drugs on a not-for-profit basis to world’s poorest countries. US pharmaceutical giant Pfizer has said it would sell its patented drugs on a not-for-profit basis to the world’s poorest countries, as part of a new initiative announced at the World Economic Forum in Davos. “An Accord for a Healthier World” focuses on …

Cheap version of Merck Covid pill to be made for poorer nations
2 years, 11 months ago

Cheap version of Merck Covid pill to be made for poorer nations

India Today  

A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck & Co's Covid-19 pill molnupiravir for poorer nations, widening access to a drug seen as a weapon in fighting the pandemic. The agreement, negotiated by the UN-backed Medicines Patent Pool with Merck, allows 27 generic drugmakers from India, China and other countries …

Pfizer pill becomes 1st US-authorized home COVID treatment
3 years ago

Pfizer pill becomes 1st US-authorized home COVID treatment

Associated Press  

WASHINGTON — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron …

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment
3 years ago

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment

News 18  

U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that …

Pfizer pill becomes 1st U.S.-authorized home COVID treatment
3 years ago

Pfizer pill becomes 1st U.S.-authorized home COVID treatment

LA Times  

Americans will be able to take a pill by Pfizer at home to head off the worst effects of the coronavirus. U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the coronavirus. But Pfizer’s drug is all but certain …

Pfizer and Merck covid-19 pills are coming soon in the US, but other countries will have to wait
3 years ago

Pfizer and Merck covid-19 pills are coming soon in the US, but other countries will have to wait

Live Mint  

Promising Covid-19 treatment pills are likely to take longer to reach patients in low- and middle-income countries than in rich ones because of manufacturing and pricing obstacles, despite efforts by drugmakers to make them more available, drug-access advocates and public-health experts say. Yet drug-access advocates and public-health experts express concern that the pills will arrive months later in poor countries …

Pfizer licenses promising covid-19 pill to UN-backed nonprofit
3 years, 1 month ago

Pfizer licenses promising covid-19 pill to UN-backed nonprofit

Live Mint  

Pfizer Inc. is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. Under the licensing agreement, the United Nations-backed Medicines Patent Pool will work with other drugmakers to manufacture the pill for use in 95 countries, including in sub-Saharan Africa, Pfizer and …

Pfizer signs deal with UN-backed group to let other companies make its COVID-19 pill
3 years, 1 month ago

Pfizer signs deal with UN-backed group to let other companies make its COVID-19 pill

Daily Mail  

Pfizer Inc has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill. Pictured: People walk by the Pfizer world headquarters in New York, November 9 Generic drug companies will be allowed to produce the pill for use in 95 countries, making up about 53% of the world's population 'It's quite significant that …

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%
3 years, 1 month ago

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%

Al Jazeera  

Pharmaceutical companies are in a race to manufacture easy-to-use medication against the coronavirus. Pfizer has said its experimental antiviral pill for COVID-19 cuts risk rates of hospitalisation and death by nearly 90 percent, as drugmakers race to manufacture easy-to-use medication against the coronavirus. Of those given Pfizer’s drug within three days of symptom onset 0.8 percent were hospitalised and none …

WHO clears Pfizer's coronavirus vaccine for emergency use, poorer countries to get early access
3 years, 11 months ago

WHO clears Pfizer's coronavirus vaccine for emergency use, poorer countries to get early access

India Today  

The World Health Organization on Friday cleared Pfizer-BioNTech's coronavirus vaccine for emergency use. The clearance to Pfizer's coronavirus vaccine from the WHO means early access of the shots to poorer countries already available in Europe and North America. Now that the WHO has given its approval to Pfizer's coronavirus vaccine, it means the poorer countries may get access to the …

US advisory panel endorses Pfizer-BioNTech COVID-19 vaccine
4 years ago

US advisory panel endorses Pfizer-BioNTech COVID-19 vaccine

Al Jazeera  

The critical decision opens the door for the US Food and Drug Administration to formally approve the COVID-19 vaccine. A United States government advisory panel has endorsed the Pfizer-BioNTech COVID-19 vaccine, a critical step towards the vaccine’s final approval for eventual distribution across the country. Al Jazeera’s Patty Culhane said the FDA advisory panel’s session on Thursday, which was broadcast …

Canada approves Pfizer-BioNTech vaccine
4 years ago

Canada approves Pfizer-BioNTech vaccine

Al Jazeera  

Canadian health officials hailed the ‘critical milestone’ a day after the UK became the first country to administer the vaccine. Canadian health officials have authorised the Pfizer-BioNTech COVID-19 vaccine, hailing the development as a “critical milestone” and paving the way for the inoculant to be administered across the country. “Canadians can feel confident that the review process was rigorous and …

UK becomes first country to authorise Pfizer-BioNTech vaccine, to be rolled out next week
4 years ago

UK becomes first country to authorise Pfizer-BioNTech vaccine, to be rolled out next week

India TV News  

United Kingdom approves Pfizer Covid-19 vaccine UK on Wednesday became the first country in the world to approve the Pfizer-BioNTech vaccine for use against COVID-19 and said that it will be rolled out from next week. The study reached 170 confirmed cases of COVID-19, with the vaccine candidate BNT162b2 demonstrating 95 per cent efficacy beginning 28 days after the first …

Discover Related